Elite in Progressive Supranuclear Palsy Atypical

Massimo Filippi

Milan, IT 
Elite in Progressive Supranuclear Palsy Atypical
Milan, IT 
OverviewLocationsClinical Research

Overview

Massimo Filippi practices in Milan, Italy. Mr. Filippi is rated as an Elite expert by MediFind in the treatment of Progressive Supranuclear Palsy Atypical. His top areas of expertise are Multiple Sclerosis (MS), Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Thrombectomy, and Deep Brain Stimulation.

His clinical research consists of co-authoring 946 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 15 articles in the study of Progressive Supranuclear Palsy Atypical.

Gender
Male

Locations

Milan, Italy
Other Locations
Turin, Italy
Via Olgettina N. 60 20132, Via, 20132, Italy
Monza, Italy
Italy
San Raffaele, 20132, Italy
Pavia, Italy
Rome, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Evaluating the Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS: An Exploratory Phase IV Ambispective Study of Patients Who Previously Participated in the CLARITY/CLARITY-EXT and ORACLE MS Clinical Trials (CLASSIC-MS)
Evaluating the Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS: An Exploratory Phase IV Ambispective Study of Patients Who Previously Participated in the CLARITY/CLARITY-EXT and ORACLE MS Clinical Trials (CLASSIC-MS)
Enrollment Status: Completed
Publish Date: October 31, 2023
Intervention Type: Other
Study Drug: Cladribine
Study Phase: Phase 4
A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared With an Interferon Beta 1a (Avonex®), in Participants With Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety
A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared With an Interferon Beta 1a (Avonex®), in Participants With Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety
Enrollment Status: Terminated
Publish Date: August 05, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

946 Total Publications

Letter to the Editor. Advanced MRI in TN diagnosis and treatment.
Letter to the Editor. Advanced MRI in TN diagnosis and treatment.
Journal: Journal of neurosurgery
Published: October 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Filippi's expertise for a condition
ConditionClose
View All 24 Elite Conditions
View All 12 Distinguished Conditions
View All 26 Advanced Conditions
View All 63 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile